Virgin Herbert
SEC CIK 1786378 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VIR | Vir Biotechnology, Inc. | EVP, CSO, Research | 262.5K | — | $2.91M | 43 | 2021-07-13 | 2022-08-09 |
Most active insiders at VIR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | SVF Endurance (Cayman) Ltd | 10% | — | $9.38M |
| 2 | SB INVESTMENT ADVISERS (UK) LTD | 10% | — | $5.72M |
| 3 | SOFTBANK VISION FUND (AIV M1) L.P. | 10% | — | $2.76M |
| 4 | SATO VICKI L | Dir | — | $1.73M |
| 5 | De Backer Marianne | Pres, CEO, Dir | — | $946.9K |
| 6 | de Verneuil Vanina | EVP, GC, Corp Sec | — | $217.7K |
| 7 | Sabatini Brent | SVP, CAO | — | $113.1K |
| 8 | O'Byrne Jason | EVP, CFO | — | $68.9K |
| 9 | Eisner Mark | EVP, Chief Medical Off | — | $49.5K |
| 10 | Napolitano Janet | Dir | — | $30.2K |
Virgin Herbert made no open-market trades at VIR in the last 12 months.
Transactions 43
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-08-10 | 2022-08-09 | VIR | Vir Biotechnology, Inc. | Virgin Herbert | EVP, CSO, Research | M - OptEx | $2.43 | +78.1K | 262.5K | +42% | +$189.7K |
| D | 2022-03-11 | 2022-03-10 | VIR | Vir Biotechnology, Inc. | Virgin Herbert | EVP, CSO, Research | M - OptEx | $1.53 | +9,000 | 184.4K | +5% | +$13.8K |
| D | 2022-02-24 | 2022-02-22 | VIR | Vir Biotechnology, Inc. | Virgin Herbert | EVP, CSO, Research | M - OptEx | $1.53 | +1,375 | 176.8K | +0.8% | +$2,104 |
| D | 2022-02-24 | 2022-02-22 | VIR | Vir Biotechnology, Inc. | Virgin Herbert | EVP, CSO, Research | S - Sale+OE | $30.00 | -1,375 | 175.4K | -0.8% | -$41.2K |
| D | 2022-02-24 | 2022-02-22 | VIR | Vir Biotechnology, Inc. | Virgin Herbert | EVP, CSO, Research | A - Grant | $0.00 | +70.0K | 175.4K | +66% | $0 |
| 2022-02-22 | 2022-02-17 | VIR | Vir Biotechnology, Inc. | Virgin Herbert | EVP, CSO, Research | S - Sale | $31.93 | -2,293 | 105.4K | -2% | -$73.2K | |
| D | 2022-02-09 | 2022-02-08 | VIR | Vir Biotechnology, Inc. | Virgin Herbert | EVP, CSO, Research | M - OptEx | $1.53 | +1,375 | 109.1K | +1% | +$2,104 |
| D | 2022-02-09 | 2022-02-08 | VIR | Vir Biotechnology, Inc. | Virgin Herbert | EVP, CSO, Research | S - Sale+OE | $33.94 | -1,375 | 107.7K | -1% | -$46.7K |
| D | 2022-01-26 | 2022-01-25 | VIR | Vir Biotechnology, Inc. | Virgin Herbert | EVP, CSO, Research | S - Sale+OE | $32.46 | -1,375 | 107.7K | -1% | -$44.6K |
| D | 2022-01-26 | 2022-01-25 | VIR | Vir Biotechnology, Inc. | Virgin Herbert | EVP, CSO, Research | M - OptEx | $1.53 | +1,375 | 109.1K | +1% | +$2,104 |
| D | 2022-01-13 | 2022-01-11 | VIR | Vir Biotechnology, Inc. | Virgin Herbert | EVP, CSO, Research | S - Sale+OE | $35.10 | -1,375 | 107.7K | -1% | -$48.3K |
| D | 2022-01-13 | 2022-01-11 | VIR | Vir Biotechnology, Inc. | Virgin Herbert | EVP, CSO, Research | M - OptEx | $1.53 | +1,375 | 109.1K | +1% | +$2,104 |
| D | 2021-12-30 | 2021-12-28 | VIR | Vir Biotechnology, Inc. | Virgin Herbert | EVP, CSO, Research | S - Sale+OE | $39.95 | -1,375 | 107.7K | -1% | -$54.9K |
| D | 2021-12-30 | 2021-12-28 | VIR | Vir Biotechnology, Inc. | Virgin Herbert | EVP, CSO, Research | M - OptEx | $1.53 | +1,375 | 109.1K | +1% | +$2,104 |
| DM | 2021-12-16 | 2021-12-14+ | VIR | Vir Biotechnology, Inc. | Virgin Herbert | EVP, CSO, Research | M - OptEx | $1.53 | +4,125 | 110.5K | +4% | +$6,311 |
| DM | 2021-12-16 | 2021-12-14+ | VIR | Vir Biotechnology, Inc. | Virgin Herbert | EVP, CSO, Research | S - Sale+OE | $48.63 | -4,125 | 107.7K | -4% | -$200.6K |
| D | 2021-12-02 | 2021-11-30 | VIR | Vir Biotechnology, Inc. | Virgin Herbert | EVP, CSO, Research | M - OptEx | $1.53 | +15.1K | 122.8K | +14% | +$23.1K |
| DM | 2021-12-02 | 2021-11-30 | VIR | Vir Biotechnology, Inc. | Virgin Herbert | EVP, CSO, Research | S - Sale+OE | $49.60 | -15.1K | 121.5K | -11% | -$750.2K |
| D | 2021-11-18 | 2021-11-16 | VIR | Vir Biotechnology, Inc. | Virgin Herbert | EVP, CSO, Research | M - OptEx | $1.53 | +1,375 | 109.1K | +1% | +$2,104 |
| D | 2021-11-18 | 2021-11-16 | VIR | Vir Biotechnology, Inc. | Virgin Herbert | EVP, CSO, Research | S - Sale+OE | $32.67 | -1,375 | 107.7K | -1% | -$44.9K |
| D | 2021-11-03 | 2021-11-02 | VIR | Vir Biotechnology, Inc. | Virgin Herbert | EVP, CSO, Research | M - OptEx | $1.53 | +1,375 | 109.1K | +1% | +$2,104 |
| D | 2021-11-03 | 2021-11-02 | VIR | Vir Biotechnology, Inc. | Virgin Herbert | EVP, CSO, Research | S - Sale+OE | $36.94 | -1,375 | 107.7K | -1% | -$50.8K |
| D | 2021-10-21 | 2021-10-19 | VIR | Vir Biotechnology, Inc. | Virgin Herbert | EVP, CSO, Research | M - OptEx | $1.53 | +1,375 | 109.1K | +1% | +$2,104 |
| D | 2021-10-21 | 2021-10-19 | VIR | Vir Biotechnology, Inc. | Virgin Herbert | EVP, CSO, Research | S - Sale+OE | $38.87 | -1,375 | 107.7K | -1% | -$53.4K |
| D | 2021-10-06 | 2021-10-05 | VIR | Vir Biotechnology, Inc. | Virgin Herbert | EVP, CSO, Research | M - OptEx | $1.53 | +1,375 | 109.1K | +1% | +$2,104 |
| D | 2021-10-06 | 2021-10-05 | VIR | Vir Biotechnology, Inc. | Virgin Herbert | EVP, CSO, Research | S - Sale+OE | $33.75 | -1,375 | 107.7K | -1% | -$46.4K |
| D | 2021-09-24 | 2021-09-22 | VIR | Vir Biotechnology, Inc. | Virgin Herbert | EVP, CSO, Research | M - OptEx | $1.53 | +8,000 | 107.7K | +8% | +$12.2K |
| D | 2021-09-22 | 2021-09-21 | VIR | Vir Biotechnology, Inc. | Virgin Herbert | EVP, CSO, Research | M - OptEx | $1.53 | +4,125 | 103.8K | +4% | +$6,311 |
| D | 2021-09-22 | 2021-09-21 | VIR | Vir Biotechnology, Inc. | Virgin Herbert | EVP, CSO, Research | S - Sale+OE | $50.00 | -4,125 | 99.7K | -4% | -$206.2K |
| DM | 2021-09-09 | 2021-09-07 | VIR | Vir Biotechnology, Inc. | Virgin Herbert | EVP, CSO, Research | S - Sale+OE | $49.67 | -4,125 | 102.5K | -4% | -$204.9K |
| D | 2021-09-09 | 2021-09-07 | VIR | Vir Biotechnology, Inc. | Virgin Herbert | EVP, CSO, Research | M - OptEx | $1.53 | +4,125 | 103.8K | +4% | +$6,311 |
| D | 2021-08-26 | 2021-08-25 | VIR | Vir Biotechnology, Inc. | Virgin Herbert | EVP, CSO, Research | S - Sale+OE | $50.00 | -2,750 | 99.7K | -3% | -$137.5K |
| D | 2021-08-26 | 2021-08-25 | VIR | Vir Biotechnology, Inc. | Virgin Herbert | EVP, CSO, Research | M - OptEx | $1.53 | +2,750 | 102.5K | +3% | +$4,208 |
| D | 2021-08-25 | 2021-08-24 | VIR | Vir Biotechnology, Inc. | Virgin Herbert | EVP, CSO, Research | M - OptEx | $1.53 | +1,375 | 101.1K | +1% | +$2,104 |
| D | 2021-08-25 | 2021-08-24 | VIR | Vir Biotechnology, Inc. | Virgin Herbert | EVP, CSO, Research | S - Sale+OE | $48.00 | -1,375 | 99.7K | -1% | -$66.0K |
| D | 2021-08-24 | 2021-08-23 | VIR | Vir Biotechnology, Inc. | Virgin Herbert | EVP, CSO, Research | M - OptEx | $1.53 | +13.8K | 113.5K | +14% | +$21.0K |
| D | 2021-08-24 | 2021-08-23 | VIR | Vir Biotechnology, Inc. | Virgin Herbert | EVP, CSO, Research | S - Sale+OE | $50.00 | -13.8K | 99.7K | -12% | -$687.5K |
| D | 2021-08-11 | 2021-08-10 | VIR | Vir Biotechnology, Inc. | Virgin Herbert | EVP, CSO, Research | M - OptEx | $1.53 | +1,375 | 101.1K | +1% | +$2,104 |
| D | 2021-08-11 | 2021-08-10 | VIR | Vir Biotechnology, Inc. | Virgin Herbert | EVP, CSO, Research | S - Sale+OE | $41.00 | -1,375 | 99.7K | -1% | -$56.4K |
| D | 2021-07-28 | 2021-07-27 | VIR | Vir Biotechnology, Inc. | Virgin Herbert | EVP, CSO, Research | M - OptEx | $1.53 | +1,375 | 101.1K | +1% | +$2,104 |
| D | 2021-07-28 | 2021-07-27 | VIR | Vir Biotechnology, Inc. | Virgin Herbert | EVP, CSO, Research | S - Sale+OE | $36.72 | -1,375 | 99.7K | -1% | -$50.5K |
| D | 2021-07-14 | 2021-07-13 | VIR | Vir Biotechnology, Inc. | Virgin Herbert | EVP, CSO, Research | S - Sale+OE | $36.72 | -1,375 | 99.7K | -1% | -$50.5K |
| D | 2021-07-14 | 2021-07-13 | VIR | Vir Biotechnology, Inc. | Virgin Herbert | EVP, CSO, Research | M - OptEx | $1.53 | +1,375 | 101.1K | +1% | +$2,104 |
Purchase Sale Sale after option exercise All abbreviations